News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Presidio Pharmaceuticals, Inc. and Numerate Conclude Research Collaboration; New Lead Compounds Targeting Hepatitis C Virus Discovered



4/23/2010 10:05:04 AM

SAN FRANCISCO & SAN BRUNO, Calif.--(BUSINESS WIRE)--Presidio Pharmaceuticals, Inc., and Numerate, Inc., today announced that they have concluded their two-year collaboration to discover new compounds that target hepatitis C virus (HCV).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES